MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-03-0006273
Sriparesh Formulations Private Limited
Sriparesh Formulations Private Limited - pharma in Karimnagar, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹83.35 Lakh
▼ 6% YoY
Net profit · FY 2023
₹1.1 Lakh
Net margin 1.3%
EBITDA · FY 2023
₹8.01 Lakh
EBITDA margin 9.6%
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹4.35 Cr
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
4
As per MCA filings
About Sriparesh Formulations Private Limited
Data last updated:
Sriparesh Formulations Private Limited is a private limited company based in Karimnagar, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC102118. Its GSTIN is 36AAWCS5173R1Z4 (Telangana).
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹4.35 Cr. It is led by directors including Srinivasreddy Dhava and Raparla Rama Krishna.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 8 – 6 – 379/A Road No.6 Alkapuri Colony, Karimnagar, Telangana, India – 505001.
As per the financials filed for FY 2023, the company reported a revenue of ₹83.35 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Lakh (net margin 1.3%) and EBITDA of ₹8.01 Lakh (EBITDA margin 9.6%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
Sriparesh Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-03-0006273). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2015PTC102118
Registration Number 102118
Incorporation Date 08 December 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-03-0006273
Key People
Srinivasreddy Dhava Director Raparla Rama Krishna Director Dhulipalla Praveen Kumar Director Recognitions & Rankings of Sriparesh Formulations
Contact details
Sriparesh Formulations Private Limited's registered office is in Karimnagar, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address8 – 6 – 379/A Road No.6 Alkapuri Colony, Karimnagar, Telangana, India – 505001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sriparesh Formulations Private Limited, buy the company report.
Comprehensive company report
Sriparesh Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sriparesh Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sriparesh Formulations Private Limited, buy the company report.
Financials of Sriparesh Formulations Private Limited
FY 2023 filings availableSriparesh Formulations Private Limited reported revenue of ₹83.35 Lakh (down 6% YoY) for FY 2023.
Revenue · FY 2023
₹83.35 Lakh ▼ 6%
Net profit · FY 2023
₹1.1 Lakh margin 1.3%
EBITDA · FY 2023
₹8.01 Lakh margin 9.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 4%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 2%
5 years · compounded
▲ 28%
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 6% fall in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹83.35 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sriparesh Formulations Private Limited, buy the company report.
Board of directors of Sriparesh Formulations Private Limited
Sriparesh Formulations has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasreddy Dhava | Director | 31 Jan 2022 | 4 Years 9 Months | Current |
| Raparla Rama Krishna | Director | 08 Dec 2015 | 10 Years 11 Months | Current |
| Dhulipalla Praveen Kumar | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
| Thummala Ashok Reddy | Director | 08 Dec 2015 | 10 Years 11 Months | Current |
Auditor
Sriparesh Formulations Private Limited is audited by VARADACHARY & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VARADACHARY & CO. | FY 2023 | 004509S |
Shareholding
The shareholding of Sriparesh Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sriparesh Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jun 2018 | 100191891 | Others | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sriparesh Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sriparesh Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sriparesh Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAWCS5173R1Z4 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sriparesh Formulations Private Limited, buy the company report.
Recent activity
Sriparesh Formulations Private Limited has 6 board changes on record since 2015: 4 appointments and 2 cessations. The latest: Srinivasreddy Dhava ceased to be Additional Director on 30 Sep 2022.
AGM
Sriparesh Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Sriparesh Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ceased
Srinivasreddy Dhava ceased to be Additional Director.
Appointed
Srinivasreddy Dhava was appointed as Director.
Ceased
Dhulipalla Praveen Kumar ceased to be Additional Director.
Appointed
Dhulipalla Praveen Kumar was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100191891 was registered on 25 Jun 2018.
Appointed
Raparla Rama Krishna was appointed as Director.
Appointed
Thummala Ashok Reddy was appointed as Director.
Incorporation
08 Dec 2015
Sriparesh Formulations Private Limited was registered on 08 Dec 2015 with Roc Hyderabad & aged 10 years 11 months as per MCA records.
Frequently asked questions
Sriparesh Formulations is an active private limited company based in Karimnagar, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 December 2015 (11+ years old) and is registered under CIN U24100TG2015PTC102118.
Sriparesh Formulations has 4 current directors:
- Srinivasreddy Dhava - Director
- Raparla Rama Krishna - Director
- Dhulipalla Praveen Kumar - Director
- Thummala Ashok Reddy - Director
The latest financial statements of Sriparesh Formulations on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sriparesh Formulations is 36AAWCS5173R1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Sriparesh Formulations is U24100TG2015PTC102118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sriparesh Formulations was incorporated on 08 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srinivasreddy Dhava ceased to be Additional Director on 30 Sep 2022. Srinivasreddy Dhava was appointed as Director on 31 Jan 2022. Dhulipalla Praveen Kumar ceased to be Additional Director on 30 Nov 2021. Sriparesh Formulations has 6 board changes on record in total.
Yes, Sriparesh Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-03-0006273).
The registered office of Sriparesh Formulations is at 8 – 6 – 379A Road No.6 Alkapuri Colony, Karimnagar, Telangana, India – 505001.
Sriparesh Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages